Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 140 | 166 | 570 | 585 | 594 |
| Gross Profit | 140 | 166 | 570 | 585 | 594 |
| Operating Expenses | 24,557 | 23,971 | 19,857 | 21,110 | 18,147 |
| Operating Income | -24,417 | -23,805 | -19,287 | -20,525 | -17,553 |
| Other Income | -540 | -969 | -467 | 561 | 144 |
| Pre-tax Income | -24,957 | -24,774 | -19,754 | -19,964 | -17,409 |
| Income Tax | -340 | -761 | -681 | -55 | -173 |
| Net Income Continuous | -24,617 | -24,013 | -19,073 | -19,909 | -17,236 |
| Net Income | $-24,617 | $-24,013 | $-19,073 | $-19,909 | $-17,236 |
| EPS Basic Total Ops | -0.55 | -0.55 | -0.44 | -0.46 | -0.40 |
| EPS Basic Continuous Ops | -0.55 | -0.55 | -0.44 | -0.46 | -0.40 |
| EPS Diluted Total Ops | -0.55 | -0.55 | -0.44 | -0.46 | -0.40 |
| EPS Diluted Continuous Ops | -0.55 | -0.55 | -0.44 | -0.46 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -0.55 | -0.44 | N/A | N/A |
| EBITDA(a) | $-24,169 | $-23,563 | $-19,071 | $-20,322 | $-17,369 |